《睡眠專業人士雜誌》
星期四, 七月 23, 2026
Apnimed, Inc., announced that it has entered into a senior secured credit facility for up to $150 million with funds managed by HealthCare Royalty Partners (“HCRx”). The capital is expected to support commercial readiness activities and the planned U.S. launch of Apnimed’s lead product candidate, AD109, if approved by the […]
Update: This resolution was passed by the California State Assembly. “Today marks a historic moment for sleep medicine and public health. By formally recognizing Sleep Apnea Awareness Month, California has acknowledged what millions of families already experience every night. Sleep apnea is one of the largest and most serious undiagnosed […]
ProSomnus Sleep Technologies announced significant progress on strategic programs. The key feature is the successful FDA registration of the company’s HWO2 buccal mucosal wellness oximeter. The ProSomnus HWO2 Device enables patients to monitor their nightly health and wellness during sleep, specifically, blood oxygen saturation, pulse rate and overall use time, […]
ProSomnus Sleep Technologies announces EVO Guided. EVO Guided is a new precision, custom oral device for the treatment of Obstructive Sleep Apnea (“OSA”). FDA cleared, patented and covered by most medical insurances, EVO Guided is the first oral device bioengineered to dilate the oropharynx and the velopharynx for optimal therapeutic […]
Sleep Specialists, LLC (DBA 2Z Medical) announces that Zzoma is now covered by a growing number of leading health insurance providers. This expanded coverage significantly increases access to this innovative, mask-free treatment option for individuals with positional OSA across the United States. Zzoma is an FDA-cleared positional therapy device indicated […]
Nyxoah SA today announced the appointment of Dr. Maurits S. Boon, MD as Chief Medical Officer. Dr. Boon joins Nyxoah from Thomas Jefferson University, where he will continue part-time as a professor and Vice Chairman, Education. He is dual board-certified in otolaryngology – head and neck surgery, as well as […]
Sleep Specialists, LLC, the manufacturer of Zzoma®, the FDA-cleared positional therapy device for mild to moderate obstructive sleep apnea (OSA), announced a significant milestone today. More than 1,000 sleep specialists across the United States are now prescribing Zzoma to their patients, and over 800 sleep clinics are actively offering it […]
Sleep Specialists, LLC, the manufacturer of Zzoma® positional therapy for obstructive sleep apnea (OSA), and iSleep Physicians, a leading virtual sleep specialist practice, have announced a collaboration to improve access to effective OSA treatment options for patients nationwide, offering a comfortable and potentially mask-free alternative to traditional CPAP therapy. Zzoma […]
A machine commonly used for pain relief has shown to improve breathing in patients with obstructive sleep apnea, a clinical trial has found. Results of the TESLA trial, published today in eClinical Medicine by researchers from King’s College London and Guy’s & St Thomas’ NHS Foundation Trust, shows the potential of a […]
LivaNova PLC has announced the first patient implanted in the investigational device exemption (IDE) clinical study, “Treating Obstructive Sleep Apnea using Targeted Hypoglossal Neurostimulation” (OSPREY). The randomized controlled trial (RCT) seeks to demonstrate the safety and effectiveness of the LivaNova aura6000™ System, an implantable hypoglossal neurostimulator intended to treat adult patients with […]
